3-(Trifluoromethyl)quinoxalin-2(1H)-one

Catalog No. :
ACOQPL160
CAS No. :
58457-64-0
Molecular Formula :
C9H5F3N2O
Molecular Weight :
214.15

IUPAC Name:3-(trifluoromethyl)quinoxalin-2(1H)-one

3-(Trifluoromethyl)quinoxalin-2(1H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$62.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Trifluoromethyl)quinoxalin-2(1H)-one
IUPAC Name3-(trifluoromethyl)quinoxalin-2(1H)-one
MDL No.MFCD00275307
Molecular FormulaC9H5F3N2O
Molecular Weight214.15
SMILESO=C1NC2=C(C=CC=C2)N=C1C(F)(F)F
InChI KeyNOGLKXWLUDJZDQ-UHFFFAOYSA-N
Synonym2-HYDROXY-3-(TRIFLUOROMETHYL)QUINOXALIN;3-(TRIFLUOROMETHYL)QUINOXALIN-2-OL;3-(TRIFLUOROMETHYL)-2-QUINOXALINOL;2-Hydroxy-3-(trifluoromethyl)quinoxaline;3-(trifluoromethyl)-1H-quinoxalin-2-one;2(1H)-Quinoxalinone, 3-(trifluoromethyl)-
CAS No.58457-64-0
PubChem CID611792

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335-H412
Precautionary Statement(s)
P261-P264-P270-P271-P273-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOQPL160 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOQPL160 route product structure diagram
    ACOQPL16058457-64-0 In Stock
Inquiry

2. ACOQPL160 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACOQPL160 route product structure diagram
    ACOQPL16058457-64-0 In Stock
Inquiry

Comments (0)